Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Food Allergy Project was a prominent non-profit research and advocacy organization founded in 2006 by David and Denise Bunning to accelerate the discovery of treatments and a cure for life-threatening food allergies. The organization was a major funder of high-impact clinical and basic research at leading academic institutions, including Stanford University, Duke University, and the Children's Hospital of Philadelphia. Its funding and advocacy were instrumental in the early development of oral immunotherapy (OIT) and the identification of genetic pathways for eosinophilic esophagitis (EoE). In December 2008, the Food Allergy Project merged with the Food Allergy Initiative (FAI), which subsequently merged with the Food Allergy and Anaphylaxis Network (FAAN) in 2012 to form Food Allergy Research & Education (FARE), the world's largest non-profit dedicated to food allergy research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Food Allergy Project.